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Abstract Surflex-QMOD integrates chemical structure
and activity data to produce physically-realistic models for
binding affinity prediction. Here, we apply QMOD to a 3D-
QSAR benchmark dataset and show broad applicability to
a diverse set of targets. Testing new ligands within the
QMOD model employs automated flexible molecular
alignment, with the model itself defining the optimal pose
for each ligand. QMOD performance was compared to that
of four approaches that depended on manual alignments
(CoMFA, two variations of CoMSIA, and CMF). QMOD
showed comparable performance to the other methods on a
challenging, but structurally limited, test set. The QMOD
models were also applied to test a large and structurally
diverse dataset of ligands from ChEMBL, nearly all of
which were synthesized years after those used for model
construction. Extrapolation across diverse chemical struc-
tures was possible because the method addresses the ligand
pose problem and provides structural and geometric means
to quantitatively identify ligands within a model’s appli-
cability domain. Predictions for such ligands for the four
tested targets were highly statistically significant based on
rank correlation. Those molecules predicted to be highly
active (pKi 7:5) had a mean experimental pKi of 7.5,
with potent and structurally novel ligands being identified
by QMOD for each target.
Keywords QSAR  QMOD  Surflex  Extrapolation 
Binding mode prediction  Affinity prediction
Introduction
We introduced the Surflex-QMOD method for 3D-QSAR
(‘‘QMOD’’ hereafter) [1] as a more physically meaningful
approach than the antecedent Compass approach [2, 3],
which itself was offered as a means to improve the fidelity
of predictive models to what is understood about protein–
ligand binding interactions. We have previously shown that
the QMOD procedure is capable of making accurate pre-
dictions across varying chemical scaffolds [1], learning
non-additive structure-activity relationships [4, 5], guiding
lead optimization toward potent and diverse ligands [6],
and incorporating information derived from biophysical
experiments [7]. The QMOD procedure is complex, com-
bining aspects of molecular similarity, multiple-instance
machine-learning, and docking. This complexity has
heretofore inhibited widespread application of the
approach by large numbers of independent investigators.
Here, we report algorithmic and workflow enhance-
ments that provide a simple procedure for model induction,
broad and automatic model application, and interpretation
of model predictions. Results are presented on a set of eight
biological targets, originally assembled by Sutherland et al.
[8]. Seven targets were enzymes, including angiotensin
converting enzyme (ACE), acetylcholinesterase (ACHE),
cyclooxygenase-2 (COX2), dihydrofolate reductase
(DHFR), glycogen phosphorylase B (GPB), thermolysin,
and thrombin, and one was a ligand-gated ion channel, the
GABAAR benzodiazepine site (BZR). Direct comparisons
were made to four other QSAR approaches (CoMFA, two
versions of CoMSIA, and CMF, reported by Zhokhova and
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Baskin [9]). In addition, for four targets with ample
ChEMBL data, we report QMOD results on diverse ligands
that are beyond the reach of many QSAR methods.
The QMOD methodology builds and tests a virtual
binding site (a ‘‘pocketmol’’) in the following six steps:
1. Initial alignment hypothesis: Two or three ligands are
chosen to serve as a seed alignment hypothesis,
derived by maximizing their mutual 3D molecular
similarity. This process may be augmented using
molecular docking, with similarity being used to
identify a clique of suitable mutually-similar poses
from the docked collection.
2. Training ligand alignment generation: For each train-
ing molecule, the initial alignment hypothesis is used
to guide the generation of multiple poses (typically
100–200), again using 3D molecular similarity.
3. Probe generation: The collection of alignments for
training molecules is used to guide the placement of
small molecular probes that represent possible con-
stituents of the cognate binding pocket. This set of
probes may be filtered using experimental information
about the configurations of the binding pocket.
4. Probe subset selection: A probe subset forming an
initial pocketmol is chosen to optimize multiple
constraints: the scores of training ligands against the
pocketmol should be close to their experimental
values, the mutual similarity of the optimal poses
should be high, the spatial redundancy of the probes
low, and the total clash between the probes and the
poses should also be low.
5. Iterative model refinement: The pocketmol is refined
by iteration of adjustment of the fine positions of the
pocketmol probes (to minimize the deviation of
computed training ligand scores to experimental data)
and refinement of training ligand poses to identify the
optimal fit for each.
6. Prediction on new molecules: The final pocketmol
serves as the target of a docking-like procedure. New
molecules are flexibly fit into the pocketmol, seeking
the optimal score subject to constraints on ligand
energetics. The result produces a set of poses, each
with a score and estimates of prediction quality.
Here, we report four enhancements (in addition to work-
flow improvements that are discussed in ‘‘Methods, data,
and computational protocols’’). First, the QMOD procedure
is now fully deterministic, with a slow, stochastic, genetic
algorithm being replaced by a faster, greedy optimization
approach for probe subset selection (Step 4 above). Second,
the explored spatial volume from model induction is used
to help guide scoring of new ligands. Third, rather than
predicting single poses based only on their respective
scores, pose families are ranked based on probabilistic
criteria that combine pocketmol scores with prediction
quality metrics. Fourth, greater control is possible over
ligand conformational and alignment preferences so that
domain knowledge can be used to influence model con-
struction. These enhancements are illustrated in Figs. 1 and
2 using thrombin as a target.
Figure 1a shows three training ligands (the QMOD
alignment hypothesis) in the thrombin binding pocket
bound to benzamidine. This initial alignment was derived
through an ensemble docking procedure [10] that produced
100 poses per ligand, followed by a similarity-driven
choice of a single pose for each [7]. The position of the
benzamidine fragment of the large inhibitors was shifted
from its preferred position when unsubstituted, illustrating
the interdependence of substituent changes and molecular
alignment. The fine positions of the common substructure
shared among the three potent thrombin inhibitors varied as
well, though on a smaller scale. The training and testing
ligand sets for this target [9] all contained the substructural
fragment highlighted in orange in Fig. 1b. For congeneric
series, especially flexible ones as in this case, it can be
desirable to impose a constraint on the conformation and
alignment of a common scaffold.
Here, the particular positions of the methylene-benza-
midine from thrombin molecule 2 were used to constrain
matching subfragments in training ligands and for new
ligands. Figure 1c shows the final optimal poses for all 59
training ligands, which exhibited some minor shifts from the
constraining fragment (the penalty for variation is 1.0 kcal/-
mol/A˚2 by default). Figure 1d shows the final derived pock-
etmol alongwith the surface envelope of the union of the set of
optimal training poses. The C=O probes interacting with the
amidine of the inhibitors correspond quite closely to those of
the pair of carboxylate oxygens of Asp-189 and the main-
chain carbonyl ofGly-219 (detailed protein atoms not shown).
The collection of hydrophobic probes enclosing the upper-left
of the pocket approximated the shape of the hydrophobic
enclosure observed in the actual binding pocket.
The construct shown in Fig. 1d represents the QMOD
procedure’s complete model. The model comprises a
solution to a multi-factorial optimization problem. The
central property is that each training ligand’s maximal
pocket interaction score over the collection of poses for
that ligand is close to the experimental value. Further, the
solution is parsimonious in a quantitative sense: training
ligand pairs with similar activity levels will tend to exhibit
similar surface shape and polarity. Here, the ligands are
quite flexible, and many diverse arrangements of the sub-
stituents of the core scaffold are possible. The congruence
observed for the sulfonamide linkers and their hydrophobic
substituents is a property of the shape and composition of
the induced pocket.
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Figure 2a shows the reverse view of what is shown in
Fig. 1d. To predict binding affinities and poses for new
ligands, the model is used in an analogous fashion to a
protein structure with a collection of binding poses for
ligands whose bound configurations are known. The
explored envelope (shown in mesh) is used as an additional
soft constraint when fitting new ligands into the pocketmol:
penetrations beyond the envelope incur a penalty to
encourage identification of solutions that fit within
explored space. Figure 2b shows the highest scoring pose
for thrombin molecule 14 (predicted pKi = 7.3), which
exhibited a protrusion from the explored training pose
envelope (red arrow). Figure 2c shows well-contained
poses for molecule 14, the best of which scored slightly
lower (pKi = 7.2).
We have recently shown that binding pose prediction
from ensemble docking can be very significantly improved
by considering molecular similarity to the bound configu-
rations of prior known ligands [10] (subsequently a related
approach was reported by Kelly et al. [11]). We have
A B
C D
Fig. 1 Thrombin model construction: a PDB structure 1DWB
(thrombin/benzamidine in tan/magenta) shown with the structurally-
guided QMOD alignment hypothesis (green carbons); b the particular
pose of thr-02, with its methylene-benzamidine (MBZ) fragment
shown with orange carbons; c final predicted optimal poses of
thrombin training ligands (lavendar) with the constraining effect of
the MBZ fragment; d final pocketmol probes (pink), optimal poses,
and the surface envelope defined by the training ligands (mesh)
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adapted our approach for docking to the QMOD method in
order to improve the reliability of pose and affinity pre-
dictions. The details of the computation are presented
below, but the principle is that a calculated numerical
property of a predicted pose is transformed into a proba-
bility using statistics derived from training ligands. Prob-
abilities from three quality metrics are used to adjust the
energetic score for each pose. Families of related poses
then receive a Boltzmann-derived probability score, and
the family with the highest probability is reported.
Figure 2d shows the highest-probability pose family for
thrombin molecule 14. The predicted pKi was close to the
experimental value (just 0.4 log units low). The three
probability-normalized metrics are described in detail
below. The first is an estimate of overall molecular novelty
that considers the extent to which the full set of training
ligands has explored the spatial and compositional char-
acteristics of the new ligand. The second is an estimate of
confidence based on the maximal similarity of the new
ligand to a particular training ligand. The third is a
A B
C D
Fig. 2 Thrombin model application: a rear view of model from
Fig. 1; b top-scoring single pose of thr-14 (yellow) protruding from
the exploration envelope; c alternative poses compatible with the
envelope (cyan); d full top-ranked pose family shown within the
training envelope surface
130 J Comput Aided Mol Des (2016) 30:127–152
123
normalized value reflecting penetration into excluded vol-
ume beyond the explored training envelope. Molecule 14,
judged based on its top-ranked pose family, was not par-
ticularly novel when considered in the context of all of the
training ligands, nor did it make excessive penetration
beyond the training ligand envelope. However, it was not
structurally similar to any particular single training ligand,
but rather its surface resembled parts of multiple ligands
cobbled together, allowing QMOD to produce a good
prediction.
Results on the original Sutherland data set were robust,
and application of the derived QMOD models to diverse
ChEMBL molecules demonstrated practically useful pre-
dictive extrapolation. Together with algorithmic and
workflow enhancements, these results suggest that Surflex-
QMOD will have broad applicability for lead optimization,
and the method is being made widely available to inde-
pendent research groups.
Methods, data, and computational protocols
Surflex computational methods have been described in
detail in previous work: 3D similarity [12, 13], 2D-simi-
larity and computations involving comparisons of single
molecules to sets of molecules [14, 15], docking (including
used of multiple protein structures) [10, 16–18], and both
standard and structure-guided QMOD [1, 4, 6, 7]. Details
of algorithmic enhancements made to the QMOD proce-
dure will be described in what follows, but prior descrip-
tions will not be repeated except in abbreviated form where
needed.
Molecular data sets
The results in this work were derived from the data sum-
marized in Table 1. Ligand sets for eight biological targets
originally assembled by Sutherland et al. (reported in 2004
[8]) were taken from the archive of Zhokhova and Baskin
[9]. The overall benchmark consisted of eight data sets that
had been curated in order to analyze performance of
CoMFA, CoMSIA, and other QSAR methods using de-
signed test sets [8]. The targets, target types, and numbers
of compounds are listed in Table 1, hereafter referred to as
the ‘‘Sutherland benchmark.’’
The sets were used exactly as structured in the original
report in order to facilitate direct comparisons with previ-
ously reported results. As described in Sutherland et al. [8],
the train/test splitting procedure was designed so as to
maximize the diversity of the test set and to examine the
predictive accuracy of methods when extrapolating outside
the training set. Approximately one-third of molecules for
each target were selected by optimization using a maxi-
mum dissimilarity algorithm and assigned to the test set,
with the remaining compounds assigned to the training set.
Selection was optimized under a restraint such that the
selected test compounds had a distribution of activities
similar to that of the complete set. The structural novelty of
thrombin molecule 14 from Fig. 2 compared with typical
training ligands (see Fig. 1) is an example of the effect of
this procedure. This procedure yields more challenging
conditions for predictions than more typical random
selection approaches and was intended to measure extrap-
olative power of QSAR models in order to better reflect
future application rather than interpolation. In 2013, the
Continuous Molecular Fields (CMF) approach was
described in detail using the same data sets with the same
molecular poses [9].
For this work, new test ligand sets and associated
activity data for the eight targets were assembled by
searching the ChEMBL database for matching targets and
then obtaining the sets of compounds with target-associ-
ated bioactivities. Table 1 lists the ChEMBL target ID and
corresponding number of total assay values (N) for each
target. The 4 targets for which there were [ 2000
ChEMBL assays values (ACHE, BZR, COX2, and THR)
were used to test the screening utility of our QMOD
models (the remaining four each had less than 1000 assay
Table 1 Datasets from Sutherland et al. [8] as used by Baskin and Zhokhova [9]
Target Target type Train Test Activity range ChEMBL ID N ligands
Acetylcholinesterase (ACHE) [19] Carboxylesterase 74 37 4.3–9.5 (pIC50) 220 4910
GABAA receptor (BZR) [20] Chloride channel 98 49 5.5–8.9 (pIC50) 1,907,607 2269
Cyclooxygenase-2 (COX2) [21] Oxidoreductase 188 94 4.0–9.0 (pIC50) 230 5670
Thrombin (THR) [22] Serine protease 59 29 4.4–8.5 (pKi) 204 4546
Angiotensin-conv. enzyme (ACE) [23] Metalloprotease 76 38 2.1–9.9 (pIC50) 1808 711
Dihydrofolate reductase (DHFR) [24] Oxidoreductase 237 124 3.3–9.8 (pIC50) 202 974
Glycogen phosphorylase B (GPB) [25] Glycosyltransferase 44 22 1.3–6.8 (pKi) 4696 673
Thermolysin (THER) [26] Metalloprotease 51 25 0.5–10.2 (pKi) 3392 104
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values). The sets of total assay values were filtered to retain
compounds with molecular weight between 100–800, and
pIC50 or pKi assay values [ 4.0.
Redundancy was eliminated by using an average activity
for compounds with more than one assay value. Com-
pounds were considered outliers and therefore eliminated if
the difference between the maximum and minimum
activity values was greater than 2 log units. A 2D similarity
method was used to eliminate compounds identical to those
in the training sets. This resulted in ChEMBL datasets for
ACHE, BZR, COX2, and thrombin containing totals of
2454, 1158, 2322, and 3097 compounds, respectively.
The existence of multiple assay values for some com-
pounds provides some idea of the expected lower bound on
absolute prediction errors for the ChEMBL compounds.
The average deviations between minimum and maximum
pIC50 or pKi values for the targets ranged from roughly
0.5–1.0 log units after eliminating outliers. This is signif-
icantly higher that what is seen with biochemical assays
conducted within a single laboratory (typically 0.3–0.5 log
units).
QMOD enhancements
There were four major changes made to the QMOD algo-
rithm for the work reported here, detailed as follows.
Probe set selection
Given initial ligand alignments (typically 100–200 poses
per training molecule) and a large set of possible probes
(often many thousand), a probe subset forming an initial
pocketmol must be chosen. The initial approach for QMOD
to identify a probe subset that approximately satisfied the
desired relationship between computed and experimental
activities was done using a mixed integer programming
solver [1]. That approach required consideration of just
single poses for each molecule for the initial selection.
Subsequently, approaches were implemented that allowed
for consideration of full ligand pose pools, where the probe
set selection method simultaneously optimized fit to
experimental data as well as optimizing multiple con-
straints, as follows:
1. The scores of training ligands against the pocketmol
should be close to their experimental values. Given a
particular probe set, the score of each pose of each
ligand is computed, and the maximal value is defined
as the ligand’s score, with the corresponding pose
being considered optimal. Scores can be constrained to
be equal to some value (plus or minus a user-
settable deviation), or be constrained to be less than
or greater than a particular value. The average of the
sum of squared deviations beyond desired values (the
mean-squared-deviation or D) is optimized toward a
minimal value.
2. The mutual similarity of the optimal poses of molecule
pairs whose activities are close should be high.
Similarities of all non-self pairs of optimal poses are
computed, with the resulting values being weighted by
a Gaussian term (identical activities are weighted 1.0,
and differences in activity reduce the weight), and the
weighted values are summed and normalized to a
maximum value of 1.0. This is the parsimony (P) re-
sulting from the current probe set configuration [4].
3. The spatial redundancy of the probes should be low.
Values are set on the preferred minimal RMS deviation
between like-kind probes, below which a positive-
valued penalty is incurred. Values may be selected, for
example, to skew toward hydrophobic pocket solutions
(by limited spatial closeness of polar probes) or toward
more hydrophilic (by allowing relatively close posi-
tioning of like polar probes). This redundancy value
(R) is optimized toward a minimal value.
4. The average clash between the probe set and the
optimal poses should also be low. This creates a
preference for models in which explanations of ligand
activity are derived through favorable interactions with
pocketmol probes rather than by constructing stiff
enclosures. Average clash (a value C 0:0) is mini-
mized in absolute magnitude.
5. There should be as few probes as possible (N) while
still meeting the foregoing constraints.
Themost sophisticated of these past approachesmade use
of a genetic algorithm, but this part of the overall QMOD
computation was a bottleneck in terms of speed, and the
results, being stochastic, were more variable with respect to
initial conditions and parameters than was desirable. For this
work, the stochastic probe selection method was replaced
with a deterministic method, which improves speed and
reproducibility. The function that is minimized by compo-
sitional selection of probes is as follows:
f ¼ aDþ bð1 PÞ þ cRþ dC þ N ð1Þ
By default, the respective weights in Eq. 1 are: a ¼ 1:0,
b ¼ 20:0, c ¼ 20:0, d ¼ 1:0, and  ¼ 0:03. A improve-
ment in the overall objective function of 1.0 can be
achieved by any of the following: reduction in the devia-
tion of each ligand’s computed activity from experimental
by 1.0 pKi units, an increase in parsimony of 0.05, elimi-
nation of a redundant probe whose RMSD from its like-
kind neighbor was 0.05 less than preferred, a reduction in
average magnitude of clashing of 1.0 pKi units, or a large
reduction in the total number of probes. The high weight
c ¼ 20:0 on probe redundancy amounts to a rule to avoid
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excessively close probes, while the constraint on the total
number of probes is quite weak and simply ensures that a
new probe will improve overall fit by at least 0.03 units.
Effective optimization of probe set selection in a typical
case results in an overall score of f  6:5, with the most
important constituent terms being the MSE (D  1:5),
parsimony (P  0:75), and average clash (C  0:1).
Note that these weights were not chosen systematically
using multiple targets. Rather, using the 5HT1a ligand set
from the initial QMOD report [1], exploration of parameter
values was made with a assumed to be 1.0, and baseline
convergence was established with all other values being
zero. The other values were then increased in magnitude
sequentially (first c, then b, d, and ) to yield probe
selections with comparable convergence in terms of MSE,
but where the effects of each additional constraint were
maximized. Systematic optimization of these parameters
using multiple data sets has not been undertaken and is
likely to yield performance improvements.
Carrying out optimization of the objective function is
done using a series of greedy procedures:
1. Given the set of initial ligand alignments, find a
parsimonious pose clique. This is done by fixing the
choice of a single molecule’s pose, then selecting the
first pose of each remaining molecule as an initial
state. Then, for each pair of molecules, we try all
possible pairs of new replacement poses for those two.
If the best among the replacement choices is better
than the current best, we replace the current solution
with using the replacement choices. The process
iterates until no replacement results in an improvement
in computed parsimony.
2. Given a locally optimal pose clique, identify a
weighted probe set that optimizes the objective func-
tion f. Initialize all probe weights to 0. Using a fixed
value to change probe weights, systematically alter the
weight of each probe by the fixed value, ensuring that
probe weights remain on the interval [0, 1]. For each
weight alteration, compute f and keep track of the best
alteration. Make the single best weight change uncov-
ered. Repeat the process for up to 10,000 cycles or
until no improvement is possible. The fixed value for
probe weight changes begins with 0.2 for one iteration
of the procedure, then it is set to 0.1 for one more
iteration. The resulting weighted probe vector is
locally optimal under changes of 0.1 weight units for
any probe.
3. Given the weighted probe solution, open choices for all
ligand poses so that now the optimal pose will result
from that with maximal score for each molecule. The
same procedure just used to optimize probe weights is
repeated, but pose choice is now free. In order to limit
the computational complexity of this step, only those
probes that were ‘‘winners’’ occasionally (‘‘good
probes’’) in the previous step are considered for weight
variation in this step.
4. The real-valued probe weight vector is binarized, and
the optimization process above is repeated, but with
weight values of only 1 and 0. The final probe set
(those probes with weight 1) is locally optimal with
respect to the function f under any single binary weight
change among the good probe set.
As implemented, ten different parsimonious pose cliques
are used, each identified by fixing a single pose of either
the first or second training molecule to one of the first five
poses from the initial alignment process. For each such
initial clique, the remaining optimization process is carried
out. The result with the lowest overall value of f is the
solution that is carried forward for further refinement.
Additional refinement does not vary the composition of the
pocketmol, just the fine positions of the probes that have
been selected in this step. As the pocketmol is refined, so
too are the poses of the ligands.
In cases where selection of an optimal probe set begins
from a pre-existing probe set, the procedure is modified
slightly, never making use of fixed pose cliques. First, the
existing set of probes and poses (whose positions may have
changed from the initial QMOD procedure steps) are used
in order to find a locally optimal weighted probe vector.
Then, all probes are considered in further optimizing f, first
using real-valued weights and then using binary weights, as
above. In practice, large parts of the beginning probe set
are retained, having been the subject of previous opti-
mization. The typical composition of the resulting probe
set is generally at least 80 % original probes, with a total
number of probes slightly larger than the original set.
This is necessarily a complex algorithm, requiring both
time and a large memory footprint in order to avoid
repetitive computations (one can cache computations of
interactions scores between probes and poses as well as
similarity scores among poses of different ligands). Further
improvements are certainly possible.
Exploration envelope
For small, relatively rigid, molecules, the process of
alignment and conformational optimization to fit into a
pocketmol will not typically identify poses that reach
outside of what is seen among a set of similarly-sized
training ligands. However, as seen in Fig. 2, as molecules
become larger and more flexible, especially when branch-
ing creates opportunities for internal clashing, parts of a
ligand may protrude into unexplored parts of space where
no explicit constraints could have been learned. In order to
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encourage exploration of poses within the explored training
envelope, a small penalty has been introduced during pose
optimization. Any atomic extrusion di beyond the training
ligand envelope incurs a sigmoidal penalty, as follows, for
atom i:




The constants have not been carefully optimized, and
the values used are: g ¼ 2:0, j ¼ 0:75, and k ¼ 0:15.
With these values, excursions of 0.2 A˚ receive a penalty of
-0.05 and increase to close to -2.0 as they reach 1.5 A˚
(with the inflection point of the sigmoid being at 0.75 A˚).
Because any single protrusion is capped at a relatively
modest penalty, the structure of this term provides gener-
ally non-distortive pressure for ligands to lie within the
envelope. However, when a molecule’s score can be sig-
nificantly improved by including an excursion, such a pose
will be retained. As seen in Fig. 2, the presence of a pro-
trusion does not eliminate a pose from consideration, but
the effect of the envelope surface serves to enhance the
exploration of conforming ligand configurations.
Pose families and prediction quality metrics
Previous versions of QMOD produced a set of poses for a
molecule, ranked only by score against the pocketmol. We
have previously used pose families consisting of closely-
related ligand configurations to represent the results of
docking [17]. Recently, we generalized that notion to take
advantage of information derived from the known bound
configurations of previously studied ligands [10].
Rather than treating the final predicted pool of n poses
as individual and independent predictions, pose families
are constructed based on RMSD, and they are ranked based
on Boltzmann-derived probability scores. A given score of
x for a particular pose family means that it is expected for
the experimentally observed bound configurations of the
ligand in question to fall within that family with probability
x. To use information from other ligands, the procedure
takes an idea from statistical potentials, which derive
energy functions from observed distributions of molecular
configurational properties (typically distances). In the case
of amino-acid residues, the free-energy of interactions
between residue types i and j is given as follows [27]:





The notion is that configurations that are common in the
observed data relative to the reference state lead to a high
relative likelihood and consequently a favorable negative
energy. For docking, we used this idea to provide an
energetic correction to predicted molecular poses, where
those that appeared to be more ‘‘native-like’’ were treated
like favorable amino-acid distances. So, a group of ligand
poses that were quantitatively more similar in terms of 3D
surface properties to prior ligands would see improvements
in their corrected energies, which would then lead to a
higher probability for the pose family. Use of this approach
led to significant improvements in predictions of bound
configurations of novel ligands [10].
Here, we extend this notion to exploit quality metrics
computed for each predicted pose of a new ligand. Con-
ceptually, more native-like in the context of a machine
learning prediction means closer to the properties of the
training ligands. A direct and obvious metric is the maxi-
mal molecular similarity of a test molecule pose to any of
the final optimal training molecule poses (we have previ-
ously used this as a measure of confidence within QMOD).
Suppose we have a collection of predicted pocketmol poses
for a ligand, denoted L1...n, some of which are more like
those seen with training ligands and some not, and this is
reflected in the set of corresponding maximal similarities
S1...n.
We can use a similar formulation to Eq. 3 by expressing
the similarities of these poses to training ligand poses in
terms of probabilities. In order to do this, we estimate the
properties of the similarity distribution among the pairs of
optimal final training poses. From prior work, we have
found that such distributions tend be normally distributed
when using the Surflex-Sim metric, so we estimate l and r
for the population of all non-self pairs of poses from the
end of the QMOD model induction process (the lavendar
poses from Fig. 1). So, given a pose Li for a new molecule,
with associated maximal similarity Si, we define a correc-
tion to the energy score (wi) as follows:
pi ¼ 1 1
2











Equation 4 is simply the area under the right-hand side
(high similarity) of the observed distribution of similarity
values among the training poses. A predicted ligand pose
that looks much less like the training ligands than other
predicted poses would receive a low similarity score,
resulting in a value close to 1 from Eq. 4 and an energetic
correction of close to zero. Conversely, a predicted ligand
pose that looks very native-like compared with other poses
would receive a low probability and a large, favorable
energy correction from Eq. 5.
The corrections to pose scores may come from multiple
measures, and QMOD currently produces three quality
metrics. The similarity measurement just described
becomes the probabilistically normalized confidence
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(pConf) value. The value represents the degree to which a
particular new ligand looks quantitatively similar to a
particular training ligand. A related measurement, called
novelty (denoted pNov in its normalized form), represents
the degree to which a new ligand looks like what is covered
by the union of all training ligands. The last measure
quantifies the degree to which a particular ligand pose
penetrates beyond the training ligand envelope into pref-
erentially excluded space (pExcl). Each of these measures
for each predicted pose is compared with information
derived from what was observed among the training
ligands in order to arrive at probabilistically normalized
values, which then are used to adjust pose family proba-
bility estimates.
As just described, only the optimal final pose of each
training ligand is used to estimate the distributions for each
quality metric. Because the QMOD learning procedure
maintains a pose pool for each training ligand, it is possible
to obtain more robust estimates for the distributions by
considering all poses for each training ligand that either
geometrically close (by RMSD) to the optimal pose or are
close based on pocketmol score (the RMSD threshold is
1.0 A˚ and the score deviation threshold is 2.0 pKi units).
For large training sets, this makes little difference, but for
smaller training sets, the effects of single molecules that
may behave as outliers is minimized.
For a new ligand in the scoring process, multiple pose
families may be reported. For each, the ligand score that is
reported corresponds to the maximal (unadjusted) score for
any pose within the family. The reported pConf, pNov, and
pExcl values are the mean values from all poses within the
family. High confidence, low novelty, and minimal pene-
tration into excluded volume all tend to correlate with
lower prediction errors. In practice, thresholds of
pConf[ 0.35 (high confidence), pNov\ 0.85 (low nov-
elty), and pExcl\ 0.95 (non-extreme exclusion penetra-
tion) are used to identify subsets of ligands on which
predictions may be considered to be more accurate.
Recall from Fig. 2 that the single top-scoring pose was
not part of the top-ranked pose family, due to placement of
the sulfonamide substituent in a manner that deviated from
what had been observed in training. It is important, how-
ever, to note that use of this re-ranking approach is nec-
essarily heuristic. It may be the case that a pose for a new
ligand that is discordant with respect to similarity or
exclusion envelope penetration is, in fact, closer to physi-
cally correct than a concordant one. However, it is likely
that, in most cases, on ligands for which a reasonable
prediction might be expected, that the best prediction will
derive from a set of poses clearly similar to those observed
from training and which fall within the training envelope.
Constraints on conformation and alignment
A user may specify a constraint on either the conformation
of a substructure or may constrain both the conformation
and alignment of a substructure. The former is useful in
cases where detailed knowledge of the energetics of a
particular system provide a more accurate geometry than
the QMOD internal forcefield. The latter is useful when
either there is specific knowledge of the binding preference
of a particular moiety or where learning convergence is
otherwise difficult to obtain. Cases where flexible mole-
cules all share a common core element that does not vary
can lead to underconstraint in model-building.
In the case of thrombin, illustrated in Figs. 1 and 2,
model convergence was poor using a purely unconstrained
pocket induction procedure. However, the favored position
of the common benzamidine fragment was useful as an
‘‘anchor’’ which led to adequate convergence. The con-
straints can be upon multiple different substructures, and
penalties from deviation are specified in terms of pKi/A˚
2
(default is -1.0 for both conformation and alignment
constraints). As seen in the thrombin example, movement
of the constrained fragment does occur in a context-de-
pendent manner for different ligands. It need not be the
case that either all of the training or all of the new mole-
cules contain fragments to be constrained.
Protein structure guided hypotheses
For all targets but BZR, protein structural information was
available, and it was used for the generation of initial
alignment hypotheses (Step 1 from the Introduction). Pro-
tein structural information was not used in any other
fashion to influence the resulting models. Protein structures
were downloaded from the Protein Data Bank as biological
assemblies. Ensemble docking for generation of the seven
structure-guided QMOD hypotheses employed five struc-
tures for each target: (1) ACE structures 1UZE, 1UZF,
2C6N, 2OC2, 3L3N, (2) ACHE structures 1MAA, 2GYU,
1Q83, 1Q84, 2GYW, (3) COX2 structures 1PXX, 3LN1,
3NT1, 3RR3, 4COX, (4) DHFR structures 1DRF, 2DHF,
1HFR, 1KMS, 1MVS, (v) GPB structures 2F3P, 1AXR,
2GPA, 1XL0, 1NOI, (vi) thermolysin structures 1QF0,
4TMN, 2TMN, 1THL, 1HYT, and (vii) thrombin structures
1K21, 1CA8, 1DWB, 1BMN, and 1D3P.
The results of ensemble dockings were used as input to an
automatic procedure that selects poses maximally similar to
one-another and also to other native ligands. Procedures for
docking [10] and for identifying an alignment hypothesis
based on the combination of docking and molecular simi-
larity [7] have been described in detail previously.
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Computational procedures
The QMOD results reported here were generated using
Surflex-QMOD version 2.039, which includes all of the
algorithmic enhancements described. The current release
(v3.065) makes improvements in workflow, moving from a
script-based approach to a small number of simple com-
mands. The current release exactly reproduces scoring of
new molecules with the resulting models, and these are
available in the data archive associated with this paper.
Model induction results are statistically equivalent between
the versions, but they differ slightly due to changes in
default parameters. Details of the precise computational
procedures are available in the data archive.
Briefly, the procedure for producing a QMOD model is
as follows (illustrated using the v3.065 version):
1 sf-qmod qminit hypo0.mol2 TrainData TrainList qmh0
2 sf-qmod qmbuild qmh0 high qmh0p0
3 sf-qmod qmbuild qmh0 medium qmh0p1
4 sf-qmod qmbuild qmh0 low qmh0p2
5 [Model selection: Tau, Mean error, Parsimony]
6 sf-qmod qmscore qmh0p0 TestList qtest
Line 1 builds the initial ligand alignments and produces
the overall probe set (Steps 2 and 3 from the Introduction)
using an alignment hypothesis (Step 1). The next three
lines build full QMOD pocketmols (Steps 4 and 5) using
three different density values for polar probe selection. In
the case of thrombin, the option ‘‘-qmatch mbz-
frag.mol2’’ was used in order to enforce the pose
constraint depicted in Fig. 1. For COX2 and DHFR, each
with large training sets (188 and 237 molecules, respec-
tively), initial models were built from a fraction of the
training sets, and final models were constructed by iterative
incorporation of the remaining fractions, using the
‘‘qmadd’’ procedure (see data archive for details).
For all but COX2 and DHFR, model selection from
among the three generated was done using the three
training metrics of Kendall’s Tau, average error, and par-
simony, with each yielding a ‘‘vote.’’ The winner was
selected as the preferred model for testing (no ties were
observed). For COX2 and DHFR, each partially trained
model was tested on the next fractional training molecule
set. Rank-correlation predictive performance of the
penultimate trained models on the final fractional training
set was used for model selection.
For the benchmark data set, results are presented for all test
molecules (see Table 1 for counts) using the ‘‘qmscore’’
(Line 5 from above) with the selected model. QMOD pock-
etmols may be applied to new molecules of widely varying
structures, but, depending on the diversity and coverage of the
training set, the reliable domain of applicability varies from
model tomodel, and predictions on ligands of some structural
classes may be more accurate than others.
For the four targets with ample ChEMBL data, the
selected models were tested on data of much more diverse
chemical structural variation than represented in the
benchmark test data. We use the term ‘‘in-model’’ to
describe those molecules for which the QMOD activity
scores are most reliable. The production of distributionally
normalized novelty, confidence, and exclusion values
(pExcl, pConf, and pNov) allows for unbiased selection of
molecular subsets. For ACHE, BZR, and COX2, in-model
molecules were defined as those predicted by QMOD with
pNov\ 0.85. However, in the case of thrombin, the new
ChEMBL ligands were so different from those seen in
training that none of the molecules passed this threshold.
The in-model definition for thrombin for a new molecule
relied on raw final reported values of similarity and
exclusion penalty ([0.70 for similarity and [-0.40 for
exclusion penalty).
Scaffold novelty was characterized using 2D compar-
isons of test ligands to the full set of training ligands for a
particular target. The calculation has been previously
described [14], and it makes use of probabilistically nor-
malized 2D similarity values that are transformed into a
single log-odds score using the multinomial distribution.
Large, positive values indicate high likelihood that a par-
ticular ligand is topologically similar to the set to which it
was compared.
Data and computational protocols are freely available by
download. Software is available by request. Details may be
found at www.jainlab.org.
Statistical analysis
The primary results of QMOD model performance, both on
convergence during training and on quality of test molecule
predictions are reported using Kendall’s Tau (s) [28] and
mean absolute error. The former is a non-parametric rank-
correlation statistic on the interval ½1; 1 whose meaning
is intuitive: a value of 1 indicates equivalent ranking
between predicted and experimental values, a value of -1
indicates reversed ranking, and a value of 0 indicates no
correlation of ranks. For this work, values are considered
tied if they differ by 0.1 or less, unless otherwise specified.
Statistical significance of s can be computed analytically
for large sample sizes, but in this work, significance has
been assessed used permutation analysis (with 10,000
permutations). The advantages of s over the widely used
Pearson’s correlation (r or r2) include dependence only on
ranks, invariance to increasing monotonic transformations,
and robustness against outliers [29].
Reports of QSAR performance often make use of a term
for test set performance that is not Pearson’s correlation,
but which is also denoted r2 or R2 (or q2 for the analogous
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case of model cross-validation using a leave-one-out
scheme), popularized by use in the initial report of the
widely used CoMFA technique [30]. Here, these values
will be denoted R2pred and q
2 to distinguish from Pearson’s
r2. Recall that the values are defined as follows, where xi
















Equation 6 normalizes the predicted residual sum of
squares (numerator, denoted ‘‘PRESS’’ in the original
report of the partial-least-squares method [31]) by the
spread in the data to be predicted (the denominator) [30].
The formulation was introduced to characterize perfor-
mance of PLS under cross-validation. However, in the case
that predicted values have an equivalent mean to experi-
mental values and the slope of a line fitted against pre-
dicted/experimental values is one, the R2pred and r
2 values
are equivalent (otherwise R2pred becomes smaller than r
2).
One distinct advantage of the Pearson formulation is that it
is invariant to linear transformations, and while being
subject to poor behavior with respect to outliers, it has
good statistical properties in many situations. It has a direct
relationship to linear regression, in that r2 explains the
proportion of variance explained by the linear regression of
y on x or vice-versa.
R2pred can be made equivalent to r
2 by a linear trans-
formation of each yi to y^i as follows:
b ¼
Pn
i¼1ðxi  xÞðyi  yÞPn
i¼1ðyi  yÞ2
ð8Þ
a ¼ x by ð9Þ
y^i ¼ aþ byi ð10Þ
Brown and Muchmore [32] made this transformation to
predicted binding affinity values from MM-PBSA in order
to produce interpretable statistics on prediction deviations
(the center and slope of the values resulting from physical
simulation calculations were far from experimental values).
Here, rather than making explicit transformations on
predicted values, we report r2 values for the QMOD results
and R2pred and q
2 results from the original reports of per-
formance for other methods. Because those methods are
fundamentally regression-based, and because the statistics
of the activity values for test data were carefully controlled,
substantial differences between the two assessment types
are not likely. We report r2 for QMOD, which provides
statistically meaningful values and also produces a sensible
comparison to results from the prior work. Numerical dif-
ferences between r2 and R2pred were small, and conclusions
about methodological comparisons were done using the
same metrics. Our hope is to encourage the field to make
use of bona fide statistics that have tractable interpretations
with respect to significance [33].
Results and discussion
The primary data set for this work (the Sutherland bench-
mark) was curated as a test for QSAR methods, with an
emphasis on diverse targets and challenging blind test
ligands [8]. In the original report, ligand conformation and
alignment questions were addressed manually for 3D QSAR
methods. The procedures employed for the eight targets
were both involved and target specific, in some casesmaking
use of information regarding known bound ligand poses (e.g.
thrombin) and in some cases making alignments without
using knowledge of binding modes (e.g. ACHE). In all
cases, the alignments were carefully curated in order to yield
consistent substituent-based correspondences.
The goal here was to analyze the performance of the
QMOD approach using automatic procedures to derive
molecular conformation and alignment, both for the model-
building process and for scoring new ligands. For the blind
test data from the Sutherland benchmark, direct comparisons
were made to the performance of four methods, all of which
relied on the same ad hoc fixed alignment procedures
(CoMFA, two versions of CoMSIA, and CMF) [8, 9]. In
addition, the QMODmodels were testedmore thoroughly on
new datasets with molecules both structurally and tempo-
rally distant from the training sets, curated from ChEMBL.
There were three primary results of this study. First, the
eight targets represented in the benchmark dataset were the
most diverse set tested to date for QMOD. Performance for
QMOD, using a physically realistic, automated, and model-
driven alignment method, was comparable to the methods
that relied upon manual ligand alignments. For all eight
targets, QMOD produced statistically significant rank cor-
relations for predicted activities of test compounds. Sec-
ond, the QMOD ligand alignments, in all cases, were
significantly different from the manual alignments used by
other methods. For the enzymes, where crystallographic
data were available, the QMOD alignments were physi-
cally plausible in all seven cases, whereas the manual
alignments clearly were not for multiple targets. In the
remaining case (BZR), the QMOD alignment was very
different from the manual diazepine-based one, but the
QMOD model corresponded well to a homology-based
BZR binding site structure. Third, for the four cases where
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ChEMBL data were plentiful, QMOD predictions were
statistically significant in their correlation with experi-
mental activities, and QMOD was able to identify potent
and structurally novel ligands reported years in the future
from the ligands used for training.
Tables 2 and 3 show the training and test results for
QMOD and the average of the fixed-alignment methods.
Summary statistics are given for the four fixed-alignment
methods for two reasons. First, the inter-target variation in
performance was much larger than the inter-method vari-
ation (single factor ANOVA yielded a p value[0.5 for
both training and testing performance). Second, the focus
here is not on direct comparison of particular methods.
Rather, the question is whether automatic and generally
applicable alignment and conformation selection can pro-
vide robust performance on challenging QSAR data sets
and produce practically useful results on structurally
diverse ligands that would not be easily modeled using
widely used QSAR approaches.
For the training performance measures, QMOD’s results
come from a de novo re-fit of training molecules to the
induced model (not from cross-validation). This is a mea-
surement of model convergence, and it is not intended to be
a direct estimate of future predictive accuracy. In all cases,
QMOD derived models converged. When training
molecules were fit into the pocketmol in order to optimize
binding interactions through variation of conformation and
alignment, the scores resulting from identification of the
top-ranked pose families were close to experimental val-
ues. In all cases, the ranking produced was highly statis-
tically significant. The fixed-alignment methods all
produced similar results with respect to internally opti-
mized cross-validation performance (with a somewhat
higher level of variation in the case of GPB).
As shown in Table 3, QMOD produced statistically
significant rank correlations for all eight targets on the
Sutherland benchmark’s designed test sets. In terms of
average error, four cases yielded deviations of less than 0.7
pKi units (1.0 kcal/mol), two of 1.0 units (\1.5 kcal/mol),
and two produced significantly higher mean error values
(equivalent to 2.2–2.3 kcal/mol). Note that in a case such
as BZR, with a limited range of experimental activity
values relative to expected assay noise, measures such as
Pearson’s correlation may not be as reflective of predictive
power as rank correlation measures such as s. For the
thrombin case, the fixed-alignment methods produced high
performance with very little inter-method variation,
appearing to show a marginal advantage over QMOD.
However, taken together, characterized by R2pred for all of
the individual methods (data not shown), the blind test
results reflected much greater inter-target variation than
inter-method variation (p[ 0:5 by single-factor ANOVA).
In direct head-to-head comparisons, QMOD did not con-
sistently outperform any other method, nor vice versa,
either when comparing raw R2pred values (without consid-
ering confidence intervals) or when comparing such values
in the context of confidence intervals computed by per-
mutation analysis for QMOD (in this latter case, there were
very few differences to count).
While there was not a numerical performance advantage
for QMOD within this set of blind tests, the fact that the
method addresses the conformation and alignment problem
in a general and automatic fashion is a distinct advantage.
Sutherland et al. [8] noted that, while the field-based 3D
Table 2 Training results for the complete Sutherland benchmark
QMOD Fixed-alignment methods
s s p val Avg Err r2 q2 q2 CI SD
ACHE 0.60 \0.001 0.65 0.59 0.52 0.43–0.61 0.05
BZR 0.62 \0.001 0.38 0.52 0.40 0.29–0.50 0.05
COX2 0.51 \0.001 0.65 0.40 0.52 0.38–0.65 0.07
THR 0.66 \0.001 0.48 0.65 0.67 0.54–0.80 0.07
ACE 0.69 \0.001 1.01 0.73 0.68 0.62–0.74 0.03
DHFR 0.56 \0.001 0.88 0.54 0.57 0.41–0.72 0.08
GPB 0.39 \0.001 0.69 0.43 0.54 0.27–0.81 0.13
THER 0.70 \0.001 1.09 0.65 0.54 0.46–0.62 0.04
Table 3 Test results for the
complete Sutherland benchmark
QMOD Fixed-alignment methods
s s p val Avg Err r2 R2pred R
2
pred CI SD
ACHE 0.60 \0.001 0.68 0.56 0.50 0.31–0.69 0.10
BZR 0.42 \0.001 0.65 0.27 0.10 -0.07 to 0.27 0.08
COX2 0.39 \0.001 1.01 0.22 0.21 -0.10 to 0.51 0.15
THR 0.51 \0.001 0.69 0.42 0.61 0.53–0.69 0.04
ACE 0.39 \0.001 1.72 0.32 0.54 0.39–0.69 0.08
DHFR 0.55 \0.001 1.04 0.46 0.60 0.45–0.69 0.06
GPB 0.50 0.001 0.67 0.46 0.47 0.39–0.55 0.04
THER 0.42 0.002 1.63 0.39 0.44 0.20–0.67 0.12
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QSAR methods performed generally better than 2D or
2.5D methods, the methods are not tractable for screening
large collections of compounds (even of congeneric series)
due to the ‘‘manual labor involved in aligning structures.’’
In what follows, we describe each of the QMOD models,
with particular attention to the relationship between the
induced model and what is known about the actual binding
sites. The congruence of models with the physical basis for
binding interactions between ligands and their target pro-
teins is reflected in the degree to which models were able to
quantitatively predict activities for structurally novel
compounds from ChEMBL.
In what follows, the four targets for which ample
ChEMBL data were available will be discussed first,
including examples of extrapolative predictions. The overall
summary of performance on the ChEMBL experiments is
next, and the remaining four targets are discussed last.
Acetylcholinesterase (ACHE)
The mammalian acetylcholinesterase (ACHE) pocket
contains a narrow gorge about 20 A˚ deep and is comprised
of subsites including the peripheral anionic site at the gorge
entrance, an oxyanion hole along one wall of the gorge, and
the catalytic triad plus quaternary ammonium group
interaction site at the bottom of the gorge [34–36]. Con-
struction of an initial alignment hypothesis from which to
induce a QMOD model can be derived by using molecular
similarity alone. However, as we have previously shown,
structural information from protein–ligand complexes can
be utilized and benefits model performance [7]. For all
targets except BZR, structural information was used for
initial alignment derivation (see ‘‘Methods, data, and
computational protocols’’ for details) but was not used in
any other manner.
Figure 3 depicts the overall QMOD model induction for
ACHE, with the native protein pocket shown for compar-
ison. Figure 3a shows the structures of the two ACHE
ligands used to generate the ACHE alignment hypothesis
that is depicted in Fig. 3b (light green). The correspon-
dence between primary features of the ligand pair is sen-
sible, with the amines superimposed, the hydrophobic
portions occupying shared volumes, and additional close
correspondence between carbonyl oxygen atoms. However,
precise atomic correspondence of specific substituents such
as the benzyl groups does not occur due to differences in
the flexibility of the central linker and overall ligand size.
Whereas manual alignment procedures seek to enhance
such correspondence, a physical solution to the mutual in-
pocket superimposition of the two ligands identifies room
for variation. The native ligand of 1MAA (Fig. 3c) follows
a similar binding pattern across the middle of the gorge, but
it differs in composition and also in how it occupies the
ends of the pocket. It has quaternary ammonium ends that
contact the indoles of Trp286 and Trp86 connected by an
intervening 10-carbon methylene chain [37]. Figure 3d
shows the ACHE pocketmol probes and surface sur-
rounding the optimal learned poses of the training ligands.
The congruence of the learned pocketmol to the protein
pocket (tan surface) is evident.
A B C D
Fig. 3 ACHE QMOD model: a 2D structures of the training
molecules used for the ACHE hypothesis; b structure-guided
alignment hypothesis (light green); c alignment shown with the
ACHE pocket of 1MAA (tan) and native ligand (cyan); d optimal
final poses of the training ligands (purple) in the QMOD pocketmol
(probes and surface in atom color), with the 1MAA pocket (tan)
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Both the initial alignment hypothesis and the final
optimal ligand poses exhibited the characteristics seen
when looking at native binding modes for different ligands
of the same pocket. Figure 4 shows the manual fixed-
alignments alongside optimal QMOD poses and four native
ligands of the ACHE pocket in their experimentally
determined poses. The manual alignment procedure
employed three pharmacophore features: the benzyl group,
the charged nitrogen, and the carbonyl (black arrows),
achieving very tight correspondences. This atomic con-
gruence is not reflected in the relative positions of the
crystallographic ligands. All four contained quaternary
ammonium nitrogens, but none of them bound exactly the
same way despite being flexible and not sterically con-
strained. The QMOD alignments were consistent with the
variation observed experimentally among ligand variants in
a common pocket.
For ACHE, the initial ChEMBL similarity screen (see
‘‘Methods, data, and computational protocols’’) yielded a
set of 342 ChEMBL molecules. Of these 162 met the cri-
terion for being ‘‘in-model’’ (the novelty measure, pNov,
was less than 0.85). For this set, s was 0.36 (ties were set at
0.5 pKi units due to assay variability, p 	 0:001), with
mean absolute error of prediction of 1.2 log units. These
performance statistics were lower than for the Sutherland
test set, but the structural diversity was much higher (an
average 2D log-odds similarity to the training set of 66.4
compared with the benchmark test set’s value of 94.0).
These included examples with significant structural diver-
sity, especially with respect to the bottom portion of the
ACHE ligands from the training set.
Figure 5 shows ChEMBL1651131, reported 
 20 years
after the most similar training molecule. The compound
was typical of the structural diversity of the in-model
ChEMBL compounds. Of the 28 in-model molecules pre-
dicted to have activity  7.5 (called ‘‘winners’’ hereafter),
the mean experimental activity was 7.6. When considering
all 342 molecules (not just the in-model ones), prediction
quality metrics dropped slightly (s of 0.34 and mean error
of 1.4), but greater structural diversity was explored.
Within this set, 43 molecules were predicted to be winners,
and their mean experimental activity was 7.2. When con-
sidering this larger set of molecules, QMOD identified
much more structurally diverse ligands (see Fig. 5b).
ChEMBL610243 exhibited great structural deviation from
the training ligands, as reflected in the negative 2D log-
odds value.
The degree to which predictions of high activity are
believed enough to warrant follow-up, either by synthetic
chemistry effort or compound acquisition, is influenced by
the evidence supporting the prediction. The QMOD method
is not a black-box predictor of activity, but rather constructs
a physical model. Because it provides not just a numerical
prediction but also an associated set of predicted poses,
judgment can be brought to bear on particular compounds,
and design ideas can be stimulated. In Fig. 5a, the predicted
pose of the ChEMBL ligand follows that of the top half of its
near-neighbor training ligand, including correspondence of
a common carbonyl/pocket interaction. The space explored
by the other training ligands (see Fig. 3) provides a basis to
believe that space exists for the large, rigid substituent.
Quantification of the nominal novelty of the compound in
A B C
Fig. 4 QMOD ACHE training ligand poses and screening utility:
a Pharmacophoric manual alignment superimposing the benzyl,
charged nitrogen, and carbonyl groups; b QMOD optimal alignment
of training molecules; c ACHE 1MAA pocket (tan), native ligand
DME (cyan), and the native ligands of 3 aligned ACHE pockets not
used in study (2HA0-CHH in white, 2HA4-ACH in light green, and
2HA5-ETM in yellow)
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the context of the full training set increases confidence in the
prediction. In Fig. 5b, the predicted ligand has a much
higher degree of structural deviation from the set of training
ligands, but the quaternary amine corresponds with experi-
mentally observed positions of similar fragments. Further,
other interactions (the nitro-group and the carbonyl) reca-
pitulate interactions observed in known ligands. The com-
pound on the left would plausibly make a case for synthesis,
and the compound on the right would make a case for
experimental testing.
The analysis of ChEMBL results, thus far, has only
considered a set of molecules with measurable ACHE
activity. A critical question for large-scale application of
activity prediction models to guide synthetic chemistry
exploration is that of false positive rates. We identified a
randomly selected set of 15,515 ZINC drug-like molecules
to be used as decoys for assessing false positive rates under
the assumption that it is unlikely that such a set would
contain a significant proportion of true ACHE ligands with
activity  7.5. Using exactly the same procedures as for the
ChEMBL scoring, the fraction of decoys that were both in-
model and were scored as nominal winners was 0.013 %.
From the full set of ACHE ChEMBL compounds (including
those that did not pass the similarity screen), QMOD iden-
tified 3.7 % of the true winners, yielding an enrichment rate
of nearly 300-fold, which is much better than typically seen
for virtual screening using docking approaches. For the
subset of compounds that passed the similarity screen,
QMOD identified 20.9 % of the true positives.
Identification of less than half of the true positives is not
ideal, but from the perspective of real-world use in lead
optimization or scaffold replacement, performance at this
level would appear to be of practical benefit. The prior
marginal value of an untested and unsynthesized com-
pound must be considered to be relatively low, so problems
involving false negatives are not as important as problems
involving false positives. If a large proportion of relatively
inactive ligands were overpredicted, or if even a nominally
small fraction of totally inactive compounds were predicted
as winners, then whatever small number of true positives
that exist among a predicted set of winners would be
overwhelmed, resulting in a low fraction of successes.
Large-scale application of the ACHE QMOD model
considered a total of 2454 ChEMBL molecules with at
least some ACHE activity and 15,515 ZINC decoys likely
to have no activity (or very poor activity). Of this total set
of nearly 18,000 molecules, among the in-model predicted
winners, over half had activity  7.5, whereas less than
3 % of the overall compound set comprised true winners.
GABAA receptor (BZR)
The BZR dataset contained molecules with the classic
benzodiazepine scaffold as well as molecules with the
seven-membered ring nucleus fused with various hetero-
cyclic rings. For our BZR model, with no experimentally
determined protein structures, the standard de novo QMOD
procedure was used to generate an initial alignment
hypothesis, which is based on 3D molecular similarity. As
seen in Fig. 6a, three BZR training ligands (meclon-
azepam, ro07-3953, and ro16-4019) representing both the
classic and fused ring scaffolds were used to build the
hypothesis (light green). Importantly, the relative poses of
the scaffolds was very different from that observed by
A B
Fig. 5 QMOD predictions on structurally novel ACHE ligands from ChEMBL
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enforcing a strict atomic congruence of common ring
systems, as had been done for the fixed-alignment methods
(not shown). The correspondence between the ligands that
arose was somewhat surprising. In general, for cases where
issues of alignment are not easily resolved, multiple
alignment hypotheses may be employed, with the model
selection being driven by considerations including model
parsimony, convergence, and testing on new ligands.
Another consideration, which we have not quantitatively
explored, is ‘‘frustration’’ with an alignment hypothesis
during model-building, where final optimal poses change
significantly from initial ones. In this case, poses shifted
very little. Figure 6b shows the optimal final poses for all
98 BZR training ligands, and the probes and surface of the
BZR pocketmol are shown in Fig. 6c. Recently, the X-ray
structure of a glutamate-gated chloride channel was used to
construct a homology model of this binding site, which was
used to dock diazepam [38]. The QMOD BZR pocketmol
was superimposed on the homology model pocket, and
Fig. 6c shows the final poses of the hypothesis training
molecules (purple) as well as the surface of the homology
model of the BZR with docked diazepam. Although no
protein structure was used in our BZR procedure, there is a
striking similarity between the pose of the docked diaze-
pam in the BZR homology model to the poses of the
ligands with classic scaffolds in our final training poses.
As with ACHE, we followed a similar procedure to
screen a set of ChEMBL BZR ligands with known activity
and the set of ZINC decoys, the statistics of which will be
discussed later. Figure 7 shows two examples of accurate
extrapolative predictions using the BZR model. At left is
an in-model ligand whose 2D structural similarity to the
training ligands was still much lower than seen within the
Sutherland test set (a 2D log-odds of 12.7 compared with
an average of 40 for the benchmark test molecules). The
predicted pose matched the binding mode of flumazenil, a
closely related compound, from a recent homology-based
study of BZR that employed docking [39]. The carbonyl of
the training compound along with the unsubstituted nitro-
gen of the ChEMBL compound (marked with green
arrows) correspond in the QMOD alignment, and both
interacted with the hydroxyl of Thr142 in the homology-
based prediction. In the QMOD predicted alignment, the
phenyl rings (shaded in green) corresponded exactly with
one another. The manual alignment rule used in the pre-
vious work would not make these correspondences, instead
aligning the key carbonyl of the training compound with a
carbon within the imidazole of the ChEMBL compound,
and producing a geometry where the two phenyl groups
cannot be superimposed.
In Fig. 7b, a structurally novel extrapolation is shown,
with indications of corresponding parts among the pre-
dicted poses of all of the ligands. For this ChEMBL
compound, the manual alignment rule from the previous
work is simply not applicable. However, the QMOD pro-
cedure identifies a pose of ChEMBL10534 that has a
rational relationship to the other scaffolds within the
model. This b-carboline compound resulted from an
attempt to discover full BZR agonists that were structurally
unrelated to the classic benzodiazepine scaffold. [40]. Its
negative 2D log-odds score indicates no topological simi-
larity to the training compound set.
A B C
Fig. 6 BZR QMOD model: a 2D structures of the training hypothesis
molecules and the alignment generated by 3D-similarity (light green);
b optimal final poses of the training ligands; c pocketmol probes and
surface (atom color) with the hypothesis molecules (purple), and the
surface of the homology model of the GABAAR (tan) with docked
diazepam (cyan)
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The BZR target was, along with COX2, the most chal-
lenging for all methods with respect to performance on the
test set in the Sutherland benchmark. Here, on the struc-
turally diverse set of ChEMBL compounds, many of which
represent future predictions, statistical performance was
excellent. For the 129 in-model ligands, s was 0.55
(p 	 0:001, ties considered at 0.5 log units), with a mean
error of 1.0 log units. For the larger and much more diverse
set of 843 compounds that included out-of-model structures,
s was significantly worse (0.17) but was still highly statis-
tically significant (p 	 0:001), with a mean error of 1.4 log
units. Consideration of less stringent thresholds on molec-
ular novelty produced performance between these values. Of
the in-model ligands predicted to be winners, the mean
activity was 7.8, and for the set including out-of-model
compounds, mean activity of predicted winners was 7.2
Cyclooxygenase-2 (COX2)
The COX2 dataset was comprised of compounds in several
structural families grouped according to the central scaf-
fold (e.g. pyrrole, imidazole, cyclopentene, pyrazole, and
isoxazole). Nearly all inhibitors had phenyl-sulfonamide
substituents (with a few containing phenyl-methyl-sulfone
substituents), all were quite rigid, and large variations in
activity hinged upon differences in the presence or absence
of halogens on the non-sulfonamide substituents of the
central ring system. Alignment for COX2 was carried out
using the standard structure-guided protocol described
above for ACHE. Figure 8 shows the two hypothesis
molecule alignments in the derived final pocketmol along
with the bound pose of celecoxib for reference. The
alignments among the different inhibitors varied relatively
little, with the differences between the training ligands and
celecoxib in Fig. 8 exhibiting among the larger deviations.
Despite some central scaffold diversity within the COX2
dataset, there was very high 2D similarity of the COX2 test
set to the training set (an average 2D log-odds of 135).
Examination of the ChEMBL results revealed COX2
ligands with more structural variation, and these are shown
in Fig. 9. Figure 9A shows an in-model prediction with a
central phenyl ring, which, while being reasonably well
predicted, was not terribly novel. Figure 9b shows an out-
of-model prediction (pNov = 0.99) with a novel benzimi-
dazole scaffold reported over a decade later than the
nearest training ligand had been reported. If one considers
predicted ChEMBL molecules with activity  7:0, one
begins to reveal much more novel scaffolds, as depicted in
Fig. 9c. ChEMBL318881 had a significantly different
structure from the training ligands, with a 2D log-odds of
just 3.0. The corresponding 3D overlay with the most
similar training ligand (which was a phenyl methyl sul-
fone) shows ChEMBL318881 with the 4-fluorophenyl ester
group both non-planar and in the E conformation. Although
this may not be the lowest energy state, this conformation
of a 4-fluorophenyl alkyl ester is not unreasonable [41].
The ChEMBL assay data for COX2 had more variation
than for the prior two targets, with average deviations
between maximum and minimum reported activity values
among those compounds with multiple values being close
to 1.0 log units. For the 627 in-model compounds s was
0.21 (p\0:01, ties at 1.0 log units). There were 33 com-
pounds whose predicted activity values were less than 5.0,
which included some significant outliers. Considering only
those ChEMBL compounds whose predicted activity was
at least 5.0, s was 0.30 (p 	 0:001, ties at 1.0 log units).
A B
Fig. 7 QMOD predictions on structurally novel BZR ligands from ChEMBL
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It is possible to make use of multiple filters on new
compounds, which create subsets on which predictions
become more accurate. For example, considering the set
with relatively low novelty (pNov \ 0.85) and relatively
high confidence (pConf  0.35) produces 271 predictions,
with a s of 0.63 (p 	 0:001, ties at 1.0 log units). Recall
that the novelty measure considers whether a new ligand
arranges itself so as to probe the binding pocket space in a
manner that is well covered by the union of training
molecules. The confidence measure addresses whether a
particular training ligand is similar to the new ligand, as
measured in their respective predicted poses.
Thrombin
The Sutherland benchmark’s thrombin dataset contains
ligands structurally similar to the potent inhibitor
3-TAPAP, which contains a central 3-amidino-phenyl-
alanine scaffold with phenyl-sulfonyl and piperidine sub-
stituents [42]. Recall that Fig. 1 shows the initial alignment
hypothesis (guided by structural information), the con-
straining effect of the methyl-benzamidine fragment, and
the optimal final poses of the 59 training ligands. There
were moieties which were relatively fixed in the pocket
(e.g. the benzamidine) versus those with more flexibility
(e.g. the substituted piperazine groups). The pocketmol
probes formed three distinct regions corresponding to the
thrombin pocket: acceptor probes mimicking the S1 pocket
surrounding the benzamidine, and steric and donor probes
representing both the S2 pocket around the substituted
piperazines and the S4 pocket around the arylsulfonyl
groups.
Screening ChEMBL compounds using the thrombin
QMOD model provided an interesting difference from the
other ChEMBL screens. Because the benchmark training
set had little structural diversity (just a single central
scaffold), all of the 804 ChEMBL thrombin ligands scored
using the QMOD model were nominally out-of-model
(pNov  0.85), and a number of molecules had substan-
tial exclusion protrusions as well. For these reasons, the
definition of in-model utilized raw values for similarity and
exclusion penetration (similarity [ 0.70 and exclusion
penalty [  0:4), which identified 219 molecules. Fig-
ure 10 shows four ChEMBL inhibitors predicted by
QMOD to be winners. For each of the four examples, the
predicted pKi was within 0.5 log units. The 2D similarity to
the training sets of the ChEMBL molecules (2D log-odds
range of 3.0–16.9) was significantly lower than that seen in
the Sutherland benchmark’s thrombin test set (mean 2D
log-odds = 95).
The ligand shown in Fig. 10a was perhaps the most
interesting (the two in Fig. 10b, c were variations). It was
predicted to have higher activity than any training ligand
(whose maximum pKi was 8.5), and its experimental
activity exceeded that of all training ligands. Instead of
benzamidine in the S1 specificity pocket, a 1-amidinopi-
peradine is present. The linker to the S4 pocket was
completely different than that seen in the training series.
Also, the rank order among the three amidinopiperadines
was predicted correctly, with the cyclooctane filling the S4
pocket more effectively than the cyclohexane or
cyclopentane. Changes in the amine substituents created
minor variations in the predicted bound poses, but all made
similar interactions to the predicted binding pocket.
The ligand shown in Fig. 10d was one of just a few
among all of the ChEMBL ligands for the four targets that
was reported before the ligands used in the respective
training sets. The inhibitor is inogatran, whose bound
structure (PDB code 1K21) was among the five structures
chosen for alignment hypothesis guidance, so its alignment
with respect to the derived pocketmol was known. Recall
that the structural guidance aspect of the model induction
procedure only affected the initial alignment hypothesis,
not the composition of the pocketmol or the final refined
poses of the training ligands. The QMOD predicted pose
Fig. 8 COX2 QMOD model: 2D structures of training molecules for
COX2 hypothesis (top) and COX2 pocketmol (probes and surface in
atom color) with the hypothesis molecules (purple) and the native
ligand celecoxib (cyan) from structure 3LN1
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deviated by 2.4 A˚ RMS from the bound configuration of
inogatran.
For a molecule with more than ten rotatable bonds, with
such significant structural novelty, prediction of the activity
and the binding mode at this level of accuracy should be
able to support real-world application. Often, a single
scaffold has been elaborated for structure-activity rela-
tionships, including some potent examples, but the scaffold
may have liabilities that are not target-specific. In such
cases, effective SAR transfer can support scaffold
replacement. Here, given a training set with extremely
limited structural variation, rank correlations on the in-
model compounds was still highly statistically significant
(s ¼ 0.26, p 	 0:001), with predicted winners having an
average experimental activity of 7.6. Predicted binding
modes also qualitatively agreed with the well-understood
behavior of thrombin inhibitors having cationic S1 recog-
nition elements. In the thrombin case, rank correlation of
all molecules, including out-of-model ones, was not sta-
tistically significant, owing to the narrowness of the
training set compared with the diverse ChEMBL
compounds.
ChEMBL screening statistical analysis
Results for ACHE, BZR, COX2, and thrombin show how
QMOD pocketmols can be used to predict the activities and
poses of new, structurally diverse, molecules. This is pos-
sible because the QMOD model itself defines the optimal
pose of a new ligand as the pose that best fits the model,
and because the conformation and alignment optimization
procedure is fully automated. However, because models
are trained on limited structure-activity data, the utility of
model application in a screening capacity is enhanced by
making use of quantitative filtering in order to constrain the
space of molecules on which predictions are likely to be
accurate.
The procedure employed here first made use of pure 3D
similarity-based virtual screening, utilizing the initial
QMOD alignment hypotheses to identify molecules with a
baseline level of similarity to the known ligands. Next, the
models were run, with the top-ranked pose families being
considered as potentially valid predictions. In-model pre-
dictions were those whose QMOD pNov parameter was
less than 0.85 (for ACHE, BZR, and COX2), or in the case
of thrombin where raw similarity and the exclusion penalty
values exceeded particular thresholds (0.7 and -0.4,
respectively). Further, a set of decoy molecules from ZINC
were utilized in identical procedures to estimate false
positive rates.
The foregoing has described rank correlation results as
well as highlighting particular chemical structures. Table 4
summarizes results with respect to the numbers of com-
pounds within each screening and filtering stage, as well as
A B C
Fig. 9 COX2 new ChEMBL molecules: molecule pairs comprised of a training molecule (purple) with maximum similarity to a new ChEMBL
test molecule (blue) correctly predicted by QMOD to be an active COX2 ligand
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the estimates of true and false positive rates. The first group
of three columns indicate, respectively, the total number of
filtered ChEMBL compounds (see ‘‘Methods, data, and
computational protocols’’), the number in the similarity-
based subset of ChEMBL molecules, and the number of in-
model molecules. The next set of three columns indicates
the number of positives (those compounds with experi-
mental pIC50 or pKi 7:5) within each of the three sets of
molecules. The next trio of columns characterizes the
nominal winners (in-model molecules with predicted
activity  7.5) according to their total number, average
experimental activity, and the total number of true posi-
tives among the winners.
The final three of columns in Table 4 characterizes the
true positive rate, the estimated false positive rate, and the
enrichment ratio. TP percentage is simply the percentage of
total positives in the ChEMBL data set predicted to be
winners by QMOD (the parenthetical number considers the
true positives within the similarity-screened subset). The
false positive rate was the percentage of decoys predicted
Table 4 ChEMBL datasets and screening utility of the ACHE, BZR, COX2, and thrombin QMOD models
N molecules N Positives Winners TP% FP% Enrichment
ChEMBL Sim In-model ChEMBL Sim In-model N Avg pKi N Pos ChEMBL (Sim) ZINC TP/FP
ACHE 2454 342 162 493 86 57 28 7.6 18 3.7 (20.9) 0.0129 283
BZR 1158 843 129 309 234 30 34 7.8 24 7.8 (10.3) 0.9026 9
COX2 2322 1283 627 351 282 191 156 6.9 57 16.2 (20.2) 0.0064 2520
THR 3097 804 219 1069 251 81 31 7.6 19 1.8 (7.6) \0.0064 [276
A B
C D
Fig. 10 Thrombin new ChEMBL molecules: molecule pairs comprised of a training molecule (purple) with maximum similarity to a new
ChEMBL test molecule (blue), each correctly predicted to be an active thrombin ligand
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to be winners. Estimated enrichment is the TP% divided by
the FP%.
In all cases, the average experimental pKi for molecules
predicted by QMOD to be winners was high, corresponding
to 10–100 nM IC50 or Ki. For three targets (ACHE, COX2,
and thrombin), enrichment rates were very high, suggesting
sufficiently specific predictions to be useful in prioritizing
large sets of molecular candidates. A surprising outlier
within these results was the estimated false positive rate for
the BZR QMOD model, which was 100 times greater than
the average for the other three targets. Due to this much
higher rate, the computed enrichment was modest, but the
true positive recovery rate was consistent with the other
three targets. True positive rates for the full ChEMBL sets
ranged from 2 to 16 %. The corresponding rates from
among the subset that passed the similarity screen ranged
from 8 to 21 %.
The utility of a method for identification of potent new
scaffolds depends on the extent to which nominal predicted
winners have a large fraction of active molecules. Fig-
ure 11 shows the experimental activity distributions for the
large ChEMBL dataset (red curve), the similarity-screened
subset (green curve), and the set predicted to be winners by
QMOD (blue curve). Not surprisingly, the similarity-based
subset was not enriched for highly active molecules for any
of the four targets. As with docking-based virtual screen-
ing, 3D similarity screening can be effective in identifying
novel ligands that share specific binding with target
ligands, but such methods are not directly useful for
activity prediction. In contrast, the molecules predicted by
Fig. 11 Distributions of experimental activity values for sets of ChEMBL compounds for four targets
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QMOD to be winners were significantly enriched in active
molecules and depleted in inactive ones (p	 0:01 by
Kolmogorov–Smirnov).
ACE and thermolysin
Angiotensin-converting enzyme and thermolysin are zinc
metalloproteases with similar binding pockets, and
accordingly these enzymes share a subset of inhibitors,
albeit with different activities. Two ACE inhibitor drugs,
enalapril and lisinopril, resulted from rational drug design
projects based on thermolysin inhibitors [43–46]. Relevant
to the datasets used in this work, SAR and crystallographic
studies of ACE and thermolysin inhibitors revealed a
minimum set of ligand moieties desirable for inhibition: (1)
a zinc-chelating group such as a phosphonate, carboxylate,
thiolate, or hydroxamate, (2) a carbonyl oxygen that
hydrogen bonds to an active site residue, and (3) for ACE,
a carboxyl group for ionic bonding to a positively charged
residue of the enzyme [23]. In our preparation of these
datasets, the zinc-coordinating groups were deprotonated to
the charged forms known to be the enzyme-bound states.
All aspects of QMOD model induction and testing were
similar for the two targets (see Tables 2, 3) (including rank
correlation, average errors, and statistical significance for
both training and testing on the Sutherland benchmark).
Results for these two targets was numerically worse in
terms of absolute errors than for the other targets, which is
perhaps not surprising given that typical numbers of
rotatable bonds for these largely peptide-like inhibitors
often exceeded 15. Such extreme flexibility increases the
burden on model induction and convergence as well as on
the optimization of poses for new ligands. Rank-correlation
results were consistent with the other targets. In the interest
of space, this discussion will focus on ACE alone, as all
observations hold equally for thermolysin.
Figure 12a shows the structures of the ACE hypothesis
ligands and 3D structures for the ACE hypothesis and final
optimal training poses. The final training poses showed
some movement in the zinc-chelating groups, reflecting the
known structural observation that zinc-chelating moieties
have different preferred geometries [23]. Most of the zinc-
chelating groups were correctly co-localized in the final
optimal ligand poses (Fig. 12b, green arrow), but a few
were misoriented, including a phosphonate group (black
arrow).
The manual alignment procedure used previously for the
Sutherland benchmark ACE ligands, described in [23],
included constraints to superimpose the terminal carboxy-
late, the amide carbonyl, and the zinc ligand of each
molecule. These alignments often resulted in incompatible
chelation geometries, both within-class and between-class
in terms of zinc chelation group. Nevertheless, the reports
of 3D QSAR performance for the fixed alignment methods
[8, 9] (see Table 3) were slightly better than those for
QMOD. Interestingly, performance for 2D and 2.5D PLS-
based QSAR was also reported [8], and ACE was one of
only two targets where these methods performed well and
equivalently to the 3D approaches. The ACE dataset
appears to be one where it is possible to get right answer
for the ‘‘wrong’’ reason using simple regression methods,
but it represents a difficult case for a physically realistic
method, due to the size and flexibility of the ligands. In
addition, for both ACE and thermolysin, very broad
A B
Fig. 12 ACE QMOD model: a 2D structures and alignment hypothesis (purple), and b optimal final poses of the set ACE training ligands
(purple)
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activity ranges (roughly spanning 8–9 log units) present
greater difficulties for methods such as QMOD that are not
regression-based. Additional constraints on ligand align-
ments (e.g. providing preferred chelation fragment place-
ment) would likely improve both training convergence and
performance on the test set.
Dihydrofolate reductase (DHFR)
DHFR was the other target for which 2D and 2.5D methods
performed competitively with 3D methods in previous
work [8]. The DHFR dataset was composed of several
structural families, including variants of both folate and
methotrexate. Given that all methods performed well (in-
cluding non-3D ones), perhaps the most interesting aspect
of the QMOD results on this target was that the model
reflected a fully automated protocol for deriving initial and
final, physically realistic, poses for the ligands. The
Sutherland benchmark’s manual alignment of the 237
training ligands involved a labor-intensive procedure,
making use of three different crystallographic structural
templates along with numerous choices for how to position
each substituent of each, rather flexible, ligand.
Figure 13 depicts the alignment results for the QMOD
model, with the 2D ligands yielding a strongly congruent
initial alignment (light green). Some movement during
model induction occurred, as seen in Fig. 13b with the
structure of bound folate shown for reference (cyan). The
ring systems reflected the correct relative geometry based
on experimental determinations. Representative poses of
the optimal final poses of the training set is shown in
Fig. 13c. Agnostic and automated generation of poses that
have a physically meaningful relationship to reality is an
advantage of the QMOD model building procedure, even in
cases where there may be little or no numerical prediction
advantages on a particular data set. As we have previously
demonstrated [4, 7], as the structural diversity of new
ligands increases, the prediction quality for models that
match true bound ligand poses becomes much better than
for models with poor agreement with the true protein–li-
gand interactions.
Glycogen phosphorylase B
Glycogen phosphorylase catalyzes the release of glucose-1-
phosphate from glycogen, and at least four distinct binding
sites of this enzyme have been exploited as targets for type-
2 diabetes therapies [47]. One of the earliest attempts
employed glucose-analog catalytic site inhibitors [48], and
glucose-analog dataset employed here contains inhibitors
from that work [8, 25, 48, 49]. More recent studies have
focused on GPB inhibitors that bind the AMP allosteric site
with good potency (effective at nanomolar-level concen-
trations) [50].
Given that the majority of the GPB inhibitors in the
dataset used here had pKi\3:0 (millimolar or worse
effective concentrations), we did not consider this a rele-
vant dataset from the perspective of drug discovery.
Nonetheless, it was subject to the same procedures as with
the other targets, and results were very similar to those
reported for previous methods (see Tables 2, 3). Align-





Fig. 13 DHFR model: a 2D structures of training molecules,
b structure-guided DHFR alignment hypothesis (light green) and
final optimal poses for the two hypothesis molecules (purple) with
native ligand folate (cyan) from structure 1DRF, and c optimal final
poses representative training ligands (purple)
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Conclusions
We have reported results for the largest and most diverse
public data set on which the QMOD method has been
applied. The Sutherland benchmark is a challenging set for
QSAR methods by design, in that the test compounds were
identified in order to present extrapolative questions rather
than interpolative ones. However, given the limitations of
the most widely used 3D QSAR methods, the chemical
series of the test ligands, in all cases, shared underlying
scaffolds with at least some training molecules. Numerical
test prediction performance among methods relying upon
fixed alignments (CoMFA, CoMSIA, and CMF) and for
QMOD was not significantly different overall, with inter-
target variation dominating inter-method variation. The
QMOD approach exhibited some weakness on highly
flexible peptidic ligands (e.g. those of ACE and ther-
molysin), but showed strength in the particular case (BZR)
where the automated alignment procedure produced a very
different inter-scaffold correspondence than that assumed
by the other methods.
Four algorithmic enhancements contributed to the abil-
ity of QMOD to yield convergent models and to provide
interpretable results on diverse data derived from
ChEMBL: 1) the complex optimization procedure for
identifying initial pocket configurations has been engi-
neered to be deterministic and focused upon finding par-
simonious solutions; 2) the envelope of space explored by
training ligands is now explicitly characterized and pro-
vides a soft boundary into which new ligands are encour-
aged to fit; 3) predicted pose families are produced and are
ranked probabilistically, taking into account whether a pose
looks like an outlier with respect to what is known; and 4)
model building can be influenced using knowledge of
binding modes while still allowing for broad application of
the resulting models.
Application of the resulting models to large and diverse
ligand sets from ChEMBL for four targets demonstrated
four important features. First, fully automatic application
of the models to predict activity and bound poses for
structurally novel molecules was possible. Second, use of
probabilistically normalized quality criteria to define a
subset of molecular space was quantitatively useful in
identifying predictions most likely to be accurate. Third, in
all four cases, highly active molecules were identified with
novel scaffolds, and in three of these cases, estimated
enrichment rates were very high. Fourth, where such
scaffolds were identified, their predicted poses were either
clearly close to correct or presented plausible correspon-
dence to the training ligands.
The choice to make use of a 2D QSAR method, a fixed-
alignment 3D method, or a dynamic-alignment 3D QSAR
method such as QMOD depends on what is required from
the resulting models. QSAR methods that are 2D tend to be
extremely fast, can often provide interpolative predictions
that are quite accurate, and are not subject to any noise
from pose optimization (or many aspects of ligand prepa-
ration). When data are plentiful and interpolation is valu-
able, application of such methods makes sense. Even in
more complex cases, use of such methods can provide
baseline performance estimates, as had been done previ-
ously for the data sets described here, and as we have done
previously [6–8]. Methods requiring manual 3D alignment
can be useful to go beyond what is possible with 2D
methods to achieve a degree of extrapolation, as was shown
in the work by Sutherland et al. in the work that described
the data sets under study here [8]. However, there are
practical challenges in constructing complex alignments
and limitations in their breadth of application on new
molecules. Further, in cases like the GABAAR benzodi-
azepine site, intuitive and easy-to-apply alignment rules
may thwart the construction of models that generalize and
predict well.
The QMOD method offers a quantitative means to
address the ligand conformation and alignment selection
process that respects physical constraints such as ligand
energetics, can directly incorporate biophysical informa-
tion, and mirrors the protein–ligand binding process in
important ways. In cases where no information is known
about the structure of a shared binding site for a set of
ligands, an objective function based on 3D surface shape
and electrostatics is used to produce initial alignments,
which are then refined in the context of a physical model.
QMOD models constructed with or without the use of
structural knowledge using several dozen ligands from
limited chemical series known at a particular time point
can be used effectively to screen large parts of future
chemical space to identify potent ligands with novel
scaffolds.
Improvement to the QMOD method will be ongoing,
with particular attention to speed of model induction and
application, model selection questions when multiple
convergent models exist, more careful treatment molecular
charge distribution, and robustness in cases with very
flexible ligands. In addition, systematic exploration of
strategies and parameters for determination of the initial
probe configuration will likely lead to improvements in
performance. However, the results presented here suggest
that the method is ready for broad, real-world application.
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